trending Market Intelligence /marketintelligence/en/news-insights/trending/h924gnapp20rl-9uiye91q2 content esgSubNav
In This List

Shandong Xinhua Pharmaceutical adds independent nonexecutive director

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Shandong Xinhua Pharmaceutical adds independent nonexecutive director

Shandong Xinhua Pharmaceutical Co. Ltd. shareholders elected Lo Wah Wai as an independent nonexecutive director at their annual general meeting.

Lo is a director at BMI Consultants Ltd., independent nonexecutive director at Chongqing Machinery & Electric Co. Ltd. and Tenfu (Cayman) Holdings Co. Ltd., as well as outside director at Fasteps Co. Ltd.

He succeeds Chan Chung Kik, who resigned to focus on his other business commitments.

China-based Shandong Xinhua Pharmaceutical sells bulk pharmaceuticals, preparations and chemical products.